Dr. Jacqueline Squire, MD

Dr. Squire practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Squire's NPI, 1710373758, was assigned on April 7, 2015. Dr. Squire graduated from University of Miami, Miller School of Medicine in 2015. Dr. Squire holds Florida license ME136920.

Dr. Squire's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Squire's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Squire practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Squire's primary specialty in the NPI Registry, under taxonomy code 207RA0201X. Dr. Squire is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Squire's licenses on file in 3 states: Florida, Georgia and North Carolina.

Dmand AI lists asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Squire treats.

CMS data shows 2,196 Medicare services from Dr. Squire across 20 procedure codes in 2024, for 336 Medicare patients. Medicare paid $47,803 for them. Every service was in an office.

CMS counts 336 Medicare patients who saw Dr. Squire in 2024. The largest group is 65 to 74, with 194 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Squire's median patient age at 50, with 59% women.

In 2024, Dr. Squire wrote 623 Medicare Part D claims for 122 patients. 45% of them were for generic drugs. CMS names the drug for 468 of them, across 16 drugs with 11 or more claims each, at $460,418 in total drug cost. In 2023, CMS named 362 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Squire for performance year 2024, reported as part of a group. Dr. Squire accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Squire as offering telehealth.

Dmand AI links 18 papers to Dr. Squire, published from 2019 to 2025. 2022 was the busiest year, with 3. The most frequent topics are COVID-19, COVID-19 Vaccines and Vaccination. Dr. Squire has published most often in J Clin Immunol. Dr. Squire's most frequent co-authors are Avni Y. Joshi, MBBS, MD, Francis A. Farraye, MD and Jennifer Woodard Leiding, MD.

CMS Open Payments shows 37 general payments to Dr. Squire from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 68% of the total. Sanofi and Genzyme US Companies paid the most, $2,238.

Dr. Squire graduated from University of Miami, Miller School of Medicine in 2015.

Dr. Squire is in network with 7 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.